• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有延长体内半衰期的治疗性抗体片段。

Therapeutic antibody fragments with prolonged in vivo half-lives.

作者信息

Chapman A P, Antoniw P, Spitali M, West S, Stephens S, King D J

机构信息

Celltech Therapeutics, 216 Bath Rd., Slough, Berks SL1 4EN, UK.

出版信息

Nat Biotechnol. 1999 Aug;17(8):780-3. doi: 10.1038/11717.

DOI:10.1038/11717
PMID:10429243
Abstract

Antibody fragments can be isolated rapidly using techniques such as phage display and can be expressed to high levels in microbial systems. However, to date such antibody fragments have been of limited use for many therapeutic applications because they are rapidly cleared from the body. We present a strategy for the site-specific chemical modification of antibody fragments with polyethylene glycol, which results in the production of antibody fragments with long in vivo half-lives and full retention of antigen-binding properties. This technology should allow more rapid and economical production of therapeutic antibodies for chronic disease therapy.

摘要

使用噬菌体展示等技术可以快速分离抗体片段,并且它们能够在微生物系统中高水平表达。然而,迄今为止,此类抗体片段在许多治疗应用中的用途有限,因为它们会迅速从体内清除。我们提出了一种用聚乙二醇对抗体片段进行位点特异性化学修饰的策略,该策略可产生具有长体内半衰期且完全保留抗原结合特性的抗体片段。这项技术应能更快速、经济地生产用于慢性病治疗的治疗性抗体。

相似文献

1
Therapeutic antibody fragments with prolonged in vivo half-lives.具有延长体内半衰期的治疗性抗体片段。
Nat Biotechnol. 1999 Aug;17(8):780-3. doi: 10.1038/11717.
2
New strategy for the extension of the serum half-life of antibody fragments.抗体片段血清半衰期延长的新策略。
Bioconjug Chem. 2009 Dec;20(12):2286-92. doi: 10.1021/bc9002772.
3
PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.聚乙二醇化可显著延长重组甲硫氨酸酶在灵长类动物体内的半衰期并减弱其免疫原性。
Cancer Res. 2004 Sep 15;64(18):6673-8. doi: 10.1158/0008-5472.CAN-04-1822.
4
In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.抗体片段在体内靶向神经系统用于阿尔茨海默病免疫治疗及淀粉样斑块的分子成像。
J Neurochem. 2007 Jul;102(2):420-33. doi: 10.1111/j.1471-4159.2007.04591.x.
5
PEGylated antibodies and antibody fragments for improved therapy: a review.用于改善治疗的聚乙二醇化抗体和抗体片段:综述
Adv Drug Deliv Rev. 2002 Jun 17;54(4):531-45. doi: 10.1016/s0169-409x(02)00026-1.
6
Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.轻链改组导致通过噬菌体展示成功筛选出对N-糖基化GM3神经节苷脂具有功能的原核表达抗体片段。
J Immunol Methods. 2004 Oct;293(1-2):71-83. doi: 10.1016/j.jim.2004.07.002.
7
Absolute quantification of a therapeutic domain antibody using ultra-performance liquid chromatography-mass spectrometry and immunoassay.使用超高效液相色谱-质谱联用技术和免疫测定法对治疗领域抗体进行绝对定量。
Bioanalysis. 2010 Sep;2(9):1597-608. doi: 10.4155/bio.10.70.
8
A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.一种高度稳定的聚乙二醇共轭人单链抗体,在低纳摩尔浓度下可中和粒细胞巨噬细胞集落刺激因子。
Protein Eng Des Sel. 2006 Oct;19(10):461-70. doi: 10.1093/protein/gzl031. Epub 2006 Jul 25.
9
Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation.利用位点特异性聚乙二醇化调整人源化抗白细胞介素-8抗体的药代动力学特性以用于治疗应用。
Cytokine. 2001 Nov 7;16(3):106-19. doi: 10.1006/cyto.2001.0936.
10
Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.抗乙型肝炎病毒表面抗原人单链可变区片段抗体的筛选与鉴定
Hepatobiliary Pancreat Dis Int. 2006 May;5(2):237-41.

引用本文的文献

1
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.用于癌症主动靶向的抗表皮生长因子受体(EGFR)配体修饰纳米载体的表面功能化
Nanomaterials (Basel). 2025 Jan 21;15(3):158. doi: 10.3390/nano15030158.
2
Development of a predictive algorithm for the efficacy of half-life extension strategies.半衰期延长策略疗效预测算法的开发。
Int J Pharm. 2024 Jul 20;660:124382. doi: 10.1016/j.ijpharm.2024.124382. Epub 2024 Jun 23.
3
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species.
能够在多种动物物种中延长生物制剂半衰期的血清免疫球蛋白或白蛋白结合单域抗体。
Front Immunol. 2024 Jan 30;15:1346328. doi: 10.3389/fimmu.2024.1346328. eCollection 2024.
4
Site-oriented conjugation of poly(2-methacryloyloxyethyl phosphorylcholine) for enhanced brain delivery of antibody.聚(2-甲基丙烯酰氧乙基磷酰胆碱)的位点导向共轭用于增强抗体的脑内递送
Front Cell Dev Biol. 2023 Oct 18;11:1214118. doi: 10.3389/fcell.2023.1214118. eCollection 2023.
5
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.携带美登素DM1和DM4的聚乙二醇化单链抗体片段-药物偶联物靶向GD2阳性肿瘤细胞
Curr Issues Mol Biol. 2023 Oct 5;45(10):8112-8125. doi: 10.3390/cimb45100512.
6
Therapeutic Antibodies in Medicine.医学中的治疗性抗体。
Molecules. 2023 Sep 5;28(18):6438. doi: 10.3390/molecules28186438.
7
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy.拓展单克隆抗体的应用范围:免疫治疗中合成核酸递送的综述
Antibodies (Basel). 2023 Jul 6;12(3):46. doi: 10.3390/antib12030046.
8
Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins.靶向抗体药物偶联物:超越细胞毒素的Payload 研究
Molecules. 2023 Jan 17;28(3):917. doi: 10.3390/molecules28030917.
9
Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.源自古老动物的单域抗体作为针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和其他冠状病毒的广泛中和剂。
Biomed Eng Adv. 2022 Dec;4:100054. doi: 10.1016/j.bea.2022.100054. Epub 2022 Sep 18.
10
Design, synthesis and evaluation of novel, branched trident small interfering RNA nanostructures for sequence-specific RNAi activity.用于序列特异性RNA干扰活性的新型分支三叉戟小干扰RNA纳米结构的设计、合成与评估。
RSC Adv. 2019 Oct 23;9(59):34166-34171. doi: 10.1039/c9ra08071f.